These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 19536569

  • 1. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
    Hoefert S, Schmitz I, Tannapfel A, Eufinger H.
    Clin Oral Investig; 2010 Jun; 14(3):271-84. PubMed ID: 19536569
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bisphosphonates and osteonecrosis of the jaw: a retrospective study.
    Murad OM, Arora S, Farag AF, Guber HA.
    Endocr Pract; 2007 Jun; 13(3):232-8. PubMed ID: 17599853
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
    Brown JJ, Ramalingam L, Zacharin MR.
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
    [Abstract] [Full Text] [Related]

  • 9. [Osteonecrosis of the jaw].
    Drozdzowska B.
    Endokrynol Pol; 2011 Jun; 62 Suppl 3():4-9. PubMed ID: 22161980
    [Abstract] [Full Text] [Related]

  • 10. [Bisphosphonate-associated osteonecrosis of the jaw].
    Abu-Id MH, Açil Y, Gottschalk J, Kreusch T.
    Mund Kiefer Gesichtschir; 2006 Mar; 10(2):73-81. PubMed ID: 16456688
    [Abstract] [Full Text] [Related]

  • 11. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T, Cheng A, Stein B, Goss A.
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [Abstract] [Full Text] [Related]

  • 12. Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
    Wehrhan F, Hyckel P, Amann K, Ries J, Stockmann P, Schlegel K, Neukam F, Nkenke E.
    Oral Dis; 2011 May; 17(4):433-42. PubMed ID: 21366807
    [Abstract] [Full Text] [Related]

  • 13. Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene.
    Lehrer S, Montazem A, Ramanathan L, Pessin-Minsley M, Pfail J, Stock RG, Kogan R.
    J Oral Maxillofac Surg; 2009 Jan; 67(1):159-61. PubMed ID: 19070762
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.
    Ficarra G, Beninati F.
    Head Neck Pathol; 2007 Dec; 1(2):132-40. PubMed ID: 20614264
    [Abstract] [Full Text] [Related]

  • 15. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G.
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [Abstract] [Full Text] [Related]

  • 16. Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients.
    Gabbert TI, Hoffmeister B, Felsenberg D.
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):749-58. PubMed ID: 25319961
    [Abstract] [Full Text] [Related]

  • 17. Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy.
    Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW.
    J Am Dent Assoc; 2009 Oct; 140(10):1259-65. PubMed ID: 19797556
    [Abstract] [Full Text] [Related]

  • 18. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B, Drudge-Coates L, Ali S, Pati J, Nargund V, Ali E, Cheng L, Wells P.
    Urol Nurs; 2016 Oct; 36(3):111-6, 154. PubMed ID: 27501591
    [Abstract] [Full Text] [Related]

  • 19. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
    Wutzl A, Eisenmenger G, Hoffmann M, Czerny C, Moser D, Pietschmann P, Ewers R, Baumann A.
    Wien Klin Wochenschr; 2006 Aug; 118(15-16):473-8. PubMed ID: 16957978
    [Abstract] [Full Text] [Related]

  • 20. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.
    Miksad RA, Lai KC, Dodson TB, Woo SB, Treister NS, Akinyemi O, Bihrle M, Maytal G, August M, Gazelle GS, Swan JS.
    Oncologist; 2011 Aug; 16(1):121-32. PubMed ID: 21212433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.